Literature DB >> 27879573

Multimodal Analgesia Versus Intravenous Patient-Controlled Analgesia for Minimally Invasive Transforaminal Lumbar Interbody Fusion Procedures.

Kern Singh1, Daniel D Bohl1, Junyoung Ahn1, Dustin H Massel1, Benjamin C Mayo1, Ankur S Narain1, Fady Y Hijji1, Philip K Louie1, William W Long1, Krishna D Modi1, Tae D Kim1, Krishna T Kudaravalli1, Frank M Phillips1, Asokumar Buvanendran2.   

Abstract

STUDY
DESIGN: Retrospective analysis.
OBJECTIVE: To compare postoperative narcotic consumption and pain scores between multimodal analgesia (MMA) and patient-controlled analgesia (PCA) following minimally invasive transforaminal lumbar interbody fusion (MIS TLIF). SUMMARY OF BACKGROUND DATA: A multimodal analgesic approach to pain management may lead to decreased pain and narcotic consumption after orthopedic procedures. Additional evidence is, however, required to determine how MMA compares to intravenous PCA after MIS TLIF.
METHODS: Patients undergoing 1-level MIS TLIF followed by either MMA or PCA at our institution were compared in terms of inpatient pain scores, narcotic consumption, hospital length of stay, rates of surgical complications, rates of inpatient nausea/vomiting, rates of postoperative urinary retention, and rates of narcotic consumption during the months after discharge.
RESULTS: A total of 139 patients met inclusion criteria. Of these, 39 (28.1%) received MMA and 100 (71.9%) received PCA. Demographic and comorbidity characteristics did not differ between cohorts. Compared with patients receiving PCA, patients receiving MMA had a lower rate of inpatient narcotic consumption (2.8 ± 1.9 vs. 5.3 ± 4.4 oral morphine equivalents/hour, P < 0.001), a lower rate of inpatient nausea/vomiting (20.5% vs. 48.0%; P = 0.003), and a shorter hospital length of stay (53.0 ± 25.3 vs. 62.6 ± 24.4 h, P = 0.041). There were no differences in Numeric Rating Scale pain score between cohorts for day 0, postoperative day 1, or postoperative day 2 (P > 0.05 for each). There was no difference in the rate of postoperative urinary retention (P > 0.05). Similarly, there were no differences in narcotic consumption at 6 or 12 weeks postoperatively (P > 0.05 for each).
CONCLUSION: These findings suggest that MMA results in reduced inpatient hospital narcotic consumption compared with PCA after MIS TLIF. The decrease in narcotic consumption may contribute to the observed decrease in the rate of inpatient nausea/vomiting and shorter hospital length of stay. Importantly, MMA and PCA resulted in similar analgesia for patients during the inpatient stay. LEVEL OF EVIDENCE: 4.

Entities:  

Mesh:

Year:  2017        PMID: 27879573     DOI: 10.1097/BRS.0000000000001992

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  11 in total

1.  Outpatient Minimally Invasive Lumbar Fusion Using Multimodal Analgesic Management in the Ambulatory Surgery Setting.

Authors:  James M Parrish; Nathaniel W Jenkins; Thomas S Brundage; Nadia M Hrynewycz; Jeffrey Podnar; Asokumar Buvanendran; Kern Singh
Journal:  Int J Spine Surg       Date:  2020-12-29

Review 2.  Multimodal analgesia in pain management after spine surgery.

Authors:  Joon S Yoo; Junyoung Ahn; Asokumar Buvanendran; Kern Singh
Journal:  J Spine Surg       Date:  2019-09

3.  Response to Letter to the Editor by Soffin et al.

Authors:  Elliot D K Cha; Conor P Lynch; James M Parrish; Nathaniel W Jenkins; Asokumar Buvanendran; Kern Singh
Journal:  Int J Spine Surg       Date:  2021-10-08

Review 4.  Anesthesia and postoperative pain control-multimodal anesthesia protocol.

Authors:  Alisha Bhatia; Asokumar Buvanendran
Journal:  J Spine Surg       Date:  2019-09

Review 5.  Lumbar spinal fusion in the outpatient setting: an update on management, surgical approaches and planning.

Authors:  Bryce A Basques; Joseph Ferguson; Kyle N Kunze; Frank M Phillips
Journal:  J Spine Surg       Date:  2019-09

6.  Minimally Invasive Versus Open Transforaminal Lumbar Interbody Fusion Surgery: An Analysis of Opioids, Nonopioid Analgesics, and Perioperative Characteristics.

Authors:  Aaron Hockley; David Ge; Dennis Vasquez-Montes; Mohamed A Moawad; Peter Gust Passias; Thomas J Errico; Aaron J Buckland; Themistocles S Protopsaltis; Charla R Fischer
Journal:  Global Spine J       Date:  2019-02-26

7.  Preemptive analgesia after lumbar spine surgery by pregabalin and celecoxib: a prospective study.

Authors:  Nguyen Trung Kien; Phillip Geiger; Hoang Van Chuong; Nguyen Manh Cuong; Ngo Van Dinh; Dinh Cong Pho; Vu The Anh; Nguyen Truong Giang
Journal:  Drug Des Devel Ther       Date:  2019-07-03       Impact factor: 4.162

8.  Multimodal Analgesia (MMA) Versus Patient-Controlled Analgesia (PCA) for One or Two-Level Posterior Lumbar Fusion Surgery.

Authors:  Sung-Woo Choi; Hyeung-Kyu Cho; Suyeon Park; Jae Hwa Yoo; Jae Chul Lee; Min Jung Baek; Hae-Dong Jang; Joong Suk Cha; Byung-Joon Shin
Journal:  J Clin Med       Date:  2020-04-11       Impact factor: 4.241

9.  Wound infiltration with ropivacaine as an adjuvant to patient controlled analgesia for transforaminal lumbar interbody fusion: a retrospective study.

Authors:  Kunpeng Li; Changbin Ji; Dawei Luo; Hongyong Feng; Keshi Yang; Hui Xu
Journal:  BMC Anesthesiol       Date:  2020-11-18       Impact factor: 2.217

10.  Pathway for enhanced recovery after spinal surgery-a systematic review of evidence for use of individual components.

Authors:  Ana Licina; Andrew Silvers; Harry Laughlin; Jeremy Russell; Crispin Wan
Journal:  BMC Anesthesiol       Date:  2021-03-10       Impact factor: 2.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.